North America Gene Synthesis Market to 2032
Overview
The North America Gene Synthesis Market is expected to reach a 25,923.33 USD Billion by 2032 and is projected to grow at a CAGR of 45.30% from 2025 to 2032.
North America Gene Synthesis Market 2018-2032 USD Billion
North America Gene Synthesis Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3,605.41 USD Billion
- Projected Market Size (2032): 25,923.33 USD Billion
- CAGR (2025-2032): 45.30%
Key Findings of North America Gene Synthesis Market
- The North America Gene Synthesis Market was valued at 3,605.41 USD Billion in 2024.
- The North America Gene Synthesis Market is likely to grow at a CAGR of 45.30% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Custom Gene Synthesis in Product Type Segment accounted for the largest share of the market with a revenue of 2,125.76 USD Billion
- The fastest growing segment Vaccine Design in Application Segment grew Fastest with a CAGR of 46.32% during the forecast period from 2024 to 2032.
North America Gene Synthesis Market Scope
- Third Party Distributors
- Online Distribution
- Direct Tender
- Others
- Diagnostic Laboratories
- Biotech & Pharmaceutical Companies
- Academic & Research Institute
- Solid Based Synthesis
- Chip Based DNA Synthesis
- PCR Based Enzyme Synthesis
- Others
- Vaccine Design
- Therapeutic Antibodies
- Genetic Engineering
- Synthetic Biology
- Gene Library Synthesis
- Custom Gene Synthesis
- Others
- Express Gene
- Complex Gene
- Standard Gene
- Synthesizer
- Consumables
- Software & Services
North America Gene Synthesis Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3,605.41 USD Billion |
| Market Value in 2032 | 25,923.33 USD Billion |
| CAGR (2025-2032) | 45.30% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, End User, Method, Application, Product Type, Gene Type, Products & Services |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 3,605.41 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 2,681.00 USD Billion in 2024.
Segments and Scope
-
North America Gene Synthesis Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,659.50 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 46.02 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By End User
- Academic & Research Institute is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,338.37 USD Billion in the year 2024.
- Academic & Research Institute is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.84 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By Method
- PCR Based Enzyme Synthesis is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,703.65 USD Billion in the year 2024.
- Chip Based DNA Synthesis is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.05 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By Application
- Synthetic Biology is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,299.21 USD Billion in the year 2024.
- Vaccine Design is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.04 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By Product Type
- Custom Gene Synthesis is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 2,125.76 USD Billion in the year 2024.
- Gene Library Synthesis is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.08 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By Gene Type
- Standard Gene is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,565.12 USD Billion in the year 2024.
- Complex Gene is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.54 % in forecast period 2025-2032.
-
North America Gene Synthesis Market to 2032, By Products & Services
- Software & Services is the largest segment in North America Gene Synthesis Market to 2032 with a revenue of 1,500.06 USD Billion in the year 2024.
- Software & Services is the Fastest growing segment in North America Gene Synthesis Market to 2032 with a Growth rate of 45.83 % in forecast period 2025-2032.
North America Gene Synthesis Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Kaneka Eurogentec S.A. | |||
| Integrated DNA Technologies, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Twist Bioscience | |||
North America Gene Synthesis Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Gene Synthesis Market Company Profiling
Industry Related Reports
Frequently Asked Questions
North America Gene Synthesis Market Scope
- Third Party Distributors
- Online Distribution
- Direct Tender
- Others
- Diagnostic Laboratories
- Biotech & Pharmaceutical Companies
- Academic & Research Institute
- Solid Based Synthesis
- Chip Based DNA Synthesis
- PCR Based Enzyme Synthesis
- Others
- Vaccine Design
- Therapeutic Antibodies
- Genetic Engineering
- Synthetic Biology
- Gene Library Synthesis
- Custom Gene Synthesis
- Others
- Express Gene
- Complex Gene
- Standard Gene
- Synthesizer
- Consumables
- Software & Services
Frequently Asked Questions
North America Gene Synthesis Market Company Profiling
Frequently Asked Questions
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.